Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc. - Suppr | 超能文献

Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc.

出版信息

NIDA Res Monogr. 1984;52:1-153.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc.

NIDA Res Monogr. 1984;52:1-153.

2

Biological evaluation of compounds for their physical dependence potential and abuse liability. XI. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1987).

NIDA Res Monogr. 1988;81:466-84.

3

Biological evaluation of compounds for their physical dependence potential and abuse liability. XVI. Drug Evaluation Committee of the College of Problems of Drug Dependence, Inc. (1992).对化合物身体依赖性潜力和滥用倾向的生物学评估。第十六部分。药物依赖问题学院药物评估委员会（1992年）。

NIDA Res Monogr. 1993;132:437-58.

4

Biological evaluation of compounds for their dependence liability. VII. Drug Testing Program of the Committee on Problems of Drug dependence, Inc. (1983).化合物成瘾可能性的生物学评估。第七章。药物依赖问题委员会药物检测项目，公司（1983年）

NIDA Res Monogr. 1984 Mar;49:352-60.

5

Acute drug abuse reactions.急性药物滥用反应。

Med Lett Drugs Ther. 1985 Sep 13;27(696):77-80.

6

Diagnosis and management of acute drug abuse reactions.

Med Lett Drugs Ther. 1983 Sep 16;25(644):85-8.

7

Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc.

NIDA Res Monogr. 1989;95:556-77.

8

Biological evaluation of compounds for their physical dependence potential and abuse liability. IX. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc. (1985).对化合物身体依赖性潜力和滥用倾向的生物学评估。九。药物依赖问题委员会的药物测试计划，公司（1985年）。

NIDA Res Monogr. 1986;67:385-98.

9

Biological evaluation of compounds for their physical dependence potential and abuse liability. XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1990).化合物身体依赖性潜力和滥用倾向的生物学评估。第十四部分。药物依赖问题委员会动物试验委员会，公司（1990年）。

NIDA Res Monogr. 1990;105:622-39.

10

Biological evaluation of compounds for their physical dependence potential and abuse liability, XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1991).药物依赖性问题委员会化合物身体依赖性潜力和滥用倾向的生物学评估，第十四部分。药物依赖性问题委员会动物试验委员会（1991年）

NIDA Res Monogr. 1992;119:490-512.

引用本文的文献

1

Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.关于适当构建、沟通和调查减害烟草制品相关说法的建议。美国胸科学会官方政策声明。

Am J Respir Crit Care Med. 2018 Oct 15;198(8):e90-e105. doi: 10.1164/rccm.201808-1443ST.

2

A review of human drug self-administration procedures.人类药物自我给药程序综述。

Behav Pharmacol. 2013 Sep;24(5-6):384-95. doi: 10.1097/FBP.0b013e3283641c3d.

3

A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.恒河猴自我给药可卡因的辨别性刺激和强化作用的受试者内评估。

Psychopharmacology (Berl). 2009 Apr;203(2):343-53. doi: 10.1007/s00213-008-1322-5. Epub 2008 Sep 21.

4

Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.阿片类药物在人类和实验动物中的滥用倾向、行为药理学及身体依赖性潜力：来自曲马多的经验教训

Biol Psychol. 2006 Jul;73(1):90-9. doi: 10.1016/j.biopsycho.2006.01.010. Epub 2006 Feb 23.